Prana Biotechnology Limited (ADR) news

   Watch this stock
Showing stories 1 - 10 of about 36   

Articles published

PRAN 1.91 -0.04 (-1.80%)
price chart
Stocks Leading Biotech Higher: Gentiva Health Services, Inc. (NASDAQ:GTIV ...
Prana Biotechnology Limited (ADR) (NASDAQ:PRAN) announced Annual Shareholders Meeting on Nov 12, 2014 at 7:30PM EST.
Related articles »  
Short Interest in Prana Biotechnology Limited Rises By 31.1% (PRAN)
Receive News & Ratings for Prana Biotechnology Limited Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prana Biotechnology Limited and related companies with Analyst Ratings ...
Related articles »  
Stocks to Watch : Blucora, Inc. (NASDAQ:BCOR), Petroleo Brasileiro Petrobras ...
Petroleo Brasileiro Petrobras SA (ADR) (NYSE:PBR) monthly performance is -19.41%. Prana Biotechnology Limited (ADR) (NASDAQ:PRAN) announced Annual Shareholders Meeting on Nov 12, 2014 at 7:30PM EST.
Eye-Catching Stocks - The Ryland Group, Inc.(NYSE:RYL), Prana Biotechnology ...
Las Vegas, NV - September 16, 2014 - (TechSonian) - The Ryland Group, Inc.(NYSE:RYL) reported that its Ryland Homes is excited to announce the Grand Openings of eight spectacular new communities located throughout the greater Philadelphia metro ...
Active Stocks to Watch : Texas Instruments Inc. (NASDAQ:TXN), Amgen Inc ...
Prana Biotechnology Limited (ADR) (NASDAQ:PRAN) announced Annual Shareholders Meeting on Nov 12, 2014 at 7:30PM EST.
Related articles »  
Morning Buzz: Citigroup Inc. (NYSE:C), Huntington Bancshares Incorporated ...
Huntington Bancshares Incorporated (NASDAQ:HBAN) monthly performance is 0.31%. Prana Biotechnology Limited (ADR) (NASDAQ:PRAN)'s PBT2 drug has been granted the Orphan Drug designation by the U.S.
Related articles »  
Trending Tickers: Baidu Inc (ADR) (NASDAQ:BIDU), Groupon, Inc. (NASDAQ ...
On 5 September Prana Biotechnology Limited (NASDAQ:PRAN) announced the US Food and Drug Administration (FDA) has granted Orphan Drug designation to PBT2 for the treatment of Huntington Disease.
Related articles »  
Momentum Stocks in Focus - MagneGas Corporation (NASDAQ:MNGA ...
Prana Biotechnology Limited (ADR) (NASDAQ:PRAN) reported the US Food and Drug Administration (FDA) has granted Orphan Drug designation to PBT2 for the treatment of Huntington Disease.
Fast Moving Stocks : Tekmira Pharmaceuticals Corp. (NASDAQ:TKMR), Itau ...
Itau Unibanco Holding SA (ADR) (NYSE:ITUB) on Thursday its shares closed at $13.69. ... On September 8, Prana Biotechnology Limited (NASDAQ:PRAN)'s PBT2 drug has been granted the Orphan Drug designation by the U.S. FDA. The drug is indicated for ...
Stocks Alert: China Ming Yang Wind Power Group Ltd (MY), Uranium Energy ...
China Ming Yang Wind Power Group Ltd (NYSE:MY) saw -2.25% decrease in value from the previous closing price, losing -0.07 cents to move to a closing price of $3.04.
Related articles »